Italia markets open in 3 hours 37 minutes

TEVA Aug 2024 17.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,5500+0,0700 (+14,58%)
In data: 01:26PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,4800
Aperto0,5500
Denaro0,5600
Domanda0,7100
Prezzo d'esercizio17,00
Scadenza2024-08-02
Min-Max giorno0,5500 - 0,5500
Contratto - Min-MaxN/D
Volume1
Open Interest125
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.